Smoking, disease, and obdurate denial: the Australian tobacco industry in the 1980s
Objective: To contrast the Australian tobacco industry’s awareness of the diseases caused by smoking with their aggressive public denial on the relation between smoking and disease in the 1980s. Design: Analysis of 325 industry documents from the world wide web. Results: In the 1980s Australian ciga...
Gespeichert in:
Veröffentlicht in: | Tobacco control 2003-12, Vol.12 (suppl 3), p.iii23-iii30 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | iii30 |
---|---|
container_issue | suppl 3 |
container_start_page | iii23 |
container_title | Tobacco control |
container_volume | 12 |
creator | Carter, S M Chapman, S |
description | Objective: To contrast the Australian tobacco industry’s awareness of the diseases caused by smoking with their aggressive public denial on the relation between smoking and disease in the 1980s. Design: Analysis of 325 industry documents from the world wide web. Results: In the 1980s Australian cigarette manufacturers were informed constantly by the international industry of the medical consensus that smoking caused disease. In addition Philip Morris (Australia) Limited received reports of Philip Morris’ international biological research programme and visited its Richmond research facility; and WD&HO Wills part funded, co-managed, and contributed research to the British American Tobacco groups’ biological research programme. Despite this knowledge, the Australian manufacturers had a policy of arguing to their employees, decision makers, and the general public that questions of smoking and disease were unresolved. The industry catalogued the literature, developed arguments against the main claims made by health groups, and attacked public health advocates who made statements linking smoking to death and disease. Industry studies suggested that a 20–30% minority of the Australian public agreed with the industry on smoking and disease, diminishing across the decade. Conclusion: Australian manufacturers were clearly negligent in the 1980s, deliberately working to undermine Australians’ understandings of the diseases caused by smoking despite their own private knowledge. Continuing scepticism about smoking and disease, corresponding with the industry’s deceptions, exists in Australian smokers today, suggesting that their actions may have slowed the rate of decline in smoking prevalence. These revelations provide important evidence for Australian litigation and advocacy. |
doi_str_mv | 10.1136/tc.12.suppl_3.iii23 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1766119</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4027267521</sourcerecordid><originalsourceid>FETCH-LOGICAL-b438t-25fd401099dae72ff40ed4371d713c044a88465de25894c8342d76dfa8b1b0ac3</originalsourceid><addsrcrecordid>eNqNkU9v1DAQxS0EokvhEyChSEicmtQTO7bDoVK1Alq1KoIC4mY5ttN6m9hL7CD67evtrsqfE6cZzfzm6Y0eQi8BVwCEHSZdQV3Feb0eJKmcczV5hBZAmSgJAfEYLXDLaEkbRvbQsxhXGAPhDTxFexmiTUubBbq8HMON81cHhXHRqmgPCuVNETozTyrZwljv1PC2SNe2OJ5jmtTglC9S6JTWoXDebIa3ublHoBU4PkdPejVE-2JX99HX9---LE_K848fTpfH52VHiUhl3fSGYsBta5Tldd9TbA0lHAwHojGlSgjKGmPrRrRUC0Jrw5npleigw0qTfXS01V3P3WiNtn5jT64nN6rpVgbl5N8b767lVfgpgTMG0GaBNzuBKfyYbUxydFHbYVDehjlKDrSmnPAMvv4HXIV58vm5rCVAZAxwpsiW0lOIcbL9gxXAchOZTFpCLXeRyfvI8tWrP7_4fbPLKAPlFnAx2V8PezXdSJbNNfLi21J-hrOT9vvyTH7KfLXlu3H1Xw7uAHpTtFA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1781842410</pqid></control><display><type>article</type><title>Smoking, disease, and obdurate denial: the Australian tobacco industry in the 1980s</title><source>Jstor Complete Legacy</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Carter, S M ; Chapman, S</creator><creatorcontrib>Carter, S M ; Chapman, S</creatorcontrib><description>Objective: To contrast the Australian tobacco industry’s awareness of the diseases caused by smoking with their aggressive public denial on the relation between smoking and disease in the 1980s. Design: Analysis of 325 industry documents from the world wide web. Results: In the 1980s Australian cigarette manufacturers were informed constantly by the international industry of the medical consensus that smoking caused disease. In addition Philip Morris (Australia) Limited received reports of Philip Morris’ international biological research programme and visited its Richmond research facility; and WD&HO Wills part funded, co-managed, and contributed research to the British American Tobacco groups’ biological research programme. Despite this knowledge, the Australian manufacturers had a policy of arguing to their employees, decision makers, and the general public that questions of smoking and disease were unresolved. The industry catalogued the literature, developed arguments against the main claims made by health groups, and attacked public health advocates who made statements linking smoking to death and disease. Industry studies suggested that a 20–30% minority of the Australian public agreed with the industry on smoking and disease, diminishing across the decade. Conclusion: Australian manufacturers were clearly negligent in the 1980s, deliberately working to undermine Australians’ understandings of the diseases caused by smoking despite their own private knowledge. Continuing scepticism about smoking and disease, corresponding with the industry’s deceptions, exists in Australian smokers today, suggesting that their actions may have slowed the rate of decline in smoking prevalence. These revelations provide important evidence for Australian litigation and advocacy.</description><identifier>ISSN: 0964-4563</identifier><identifier>EISSN: 1468-3318</identifier><identifier>DOI: 10.1136/tc.12.suppl_3.iii23</identifier><identifier>PMID: 14645945</identifier><language>eng</language><publisher>England: BMJ Publishing Group Ltd</publisher><subject>ACCI ; Advocacy ; Agreements ; Australia ; Australian Chamber of Commerce and Industry ; BAT ; Biological activity ; Biological research ; Biomedical Research ; British American Tobacco ; CAC ; Chairman’s Advisory Conference (BAT) ; Communication ; Consumer Product Safety ; Cooperation Centre for Scientific Research Relative to Tobacco ; CORESTA ; Councils ; Denial (Psychology) ; Disease ; Documents ; Epidemiology ; GR&DC ; Group Research and Development Centre ; Humans ; Information management ; Laboratories ; Liability ; Litigation ; Philip Morris (Australia) Limited ; Philip Morris International ; PMI ; PML ; Product development ; Propaganda ; Public health ; R&D ; Research & development ; Research Paper ; scientific research group ; Smoking ; Smoking - adverse effects ; Smoking - psychology ; smoking related disease ; SRG ; TIA ; Tobacco ; Tobacco Industry ; Tobacco Institute of Australia</subject><ispartof>Tobacco control, 2003-12, Vol.12 (suppl 3), p.iii23-iii30</ispartof><rights>Copyright 2003 Tobacco Control</rights><rights>Copyright: 2003 Copyright 2003 Tobacco Control</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b438t-25fd401099dae72ff40ed4371d713c044a88465de25894c8342d76dfa8b1b0ac3</citedby><cites>FETCH-LOGICAL-b438t-25fd401099dae72ff40ed4371d713c044a88465de25894c8342d76dfa8b1b0ac3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1766119/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1766119/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14645945$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Carter, S M</creatorcontrib><creatorcontrib>Chapman, S</creatorcontrib><title>Smoking, disease, and obdurate denial: the Australian tobacco industry in the 1980s</title><title>Tobacco control</title><addtitle>Tob Control</addtitle><description>Objective: To contrast the Australian tobacco industry’s awareness of the diseases caused by smoking with their aggressive public denial on the relation between smoking and disease in the 1980s. Design: Analysis of 325 industry documents from the world wide web. Results: In the 1980s Australian cigarette manufacturers were informed constantly by the international industry of the medical consensus that smoking caused disease. In addition Philip Morris (Australia) Limited received reports of Philip Morris’ international biological research programme and visited its Richmond research facility; and WD&HO Wills part funded, co-managed, and contributed research to the British American Tobacco groups’ biological research programme. Despite this knowledge, the Australian manufacturers had a policy of arguing to their employees, decision makers, and the general public that questions of smoking and disease were unresolved. The industry catalogued the literature, developed arguments against the main claims made by health groups, and attacked public health advocates who made statements linking smoking to death and disease. Industry studies suggested that a 20–30% minority of the Australian public agreed with the industry on smoking and disease, diminishing across the decade. Conclusion: Australian manufacturers were clearly negligent in the 1980s, deliberately working to undermine Australians’ understandings of the diseases caused by smoking despite their own private knowledge. Continuing scepticism about smoking and disease, corresponding with the industry’s deceptions, exists in Australian smokers today, suggesting that their actions may have slowed the rate of decline in smoking prevalence. These revelations provide important evidence for Australian litigation and advocacy.</description><subject>ACCI</subject><subject>Advocacy</subject><subject>Agreements</subject><subject>Australia</subject><subject>Australian Chamber of Commerce and Industry</subject><subject>BAT</subject><subject>Biological activity</subject><subject>Biological research</subject><subject>Biomedical Research</subject><subject>British American Tobacco</subject><subject>CAC</subject><subject>Chairman’s Advisory Conference (BAT)</subject><subject>Communication</subject><subject>Consumer Product Safety</subject><subject>Cooperation Centre for Scientific Research Relative to Tobacco</subject><subject>CORESTA</subject><subject>Councils</subject><subject>Denial (Psychology)</subject><subject>Disease</subject><subject>Documents</subject><subject>Epidemiology</subject><subject>GR&DC</subject><subject>Group Research and Development Centre</subject><subject>Humans</subject><subject>Information management</subject><subject>Laboratories</subject><subject>Liability</subject><subject>Litigation</subject><subject>Philip Morris (Australia) Limited</subject><subject>Philip Morris International</subject><subject>PMI</subject><subject>PML</subject><subject>Product development</subject><subject>Propaganda</subject><subject>Public health</subject><subject>R&D</subject><subject>Research & development</subject><subject>Research Paper</subject><subject>scientific research group</subject><subject>Smoking</subject><subject>Smoking - adverse effects</subject><subject>Smoking - psychology</subject><subject>smoking related disease</subject><subject>SRG</subject><subject>TIA</subject><subject>Tobacco</subject><subject>Tobacco Industry</subject><subject>Tobacco Institute of Australia</subject><issn>0964-4563</issn><issn>1468-3318</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkU9v1DAQxS0EokvhEyChSEicmtQTO7bDoVK1Alq1KoIC4mY5ttN6m9hL7CD67evtrsqfE6cZzfzm6Y0eQi8BVwCEHSZdQV3Feb0eJKmcczV5hBZAmSgJAfEYLXDLaEkbRvbQsxhXGAPhDTxFexmiTUubBbq8HMON81cHhXHRqmgPCuVNETozTyrZwljv1PC2SNe2OJ5jmtTglC9S6JTWoXDebIa3ublHoBU4PkdPejVE-2JX99HX9---LE_K848fTpfH52VHiUhl3fSGYsBta5Tldd9TbA0lHAwHojGlSgjKGmPrRrRUC0Jrw5npleigw0qTfXS01V3P3WiNtn5jT64nN6rpVgbl5N8b767lVfgpgTMG0GaBNzuBKfyYbUxydFHbYVDehjlKDrSmnPAMvv4HXIV58vm5rCVAZAxwpsiW0lOIcbL9gxXAchOZTFpCLXeRyfvI8tWrP7_4fbPLKAPlFnAx2V8PezXdSJbNNfLi21J-hrOT9vvyTH7KfLXlu3H1Xw7uAHpTtFA</recordid><startdate>200312</startdate><enddate>200312</enddate><creator>Carter, S M</creator><creator>Chapman, S</creator><general>BMJ Publishing Group Ltd</general><general>BMJ Publishing Group LTD</general><general>BMJ Group</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7WY</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>883</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>HCIFZ</scope><scope>K60</scope><scope>K6~</scope><scope>K9-</scope><scope>K9.</scope><scope>M0F</scope><scope>M0K</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200312</creationdate><title>Smoking, disease, and obdurate denial: the Australian tobacco industry in the 1980s</title><author>Carter, S M ; Chapman, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b438t-25fd401099dae72ff40ed4371d713c044a88465de25894c8342d76dfa8b1b0ac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>ACCI</topic><topic>Advocacy</topic><topic>Agreements</topic><topic>Australia</topic><topic>Australian Chamber of Commerce and Industry</topic><topic>BAT</topic><topic>Biological activity</topic><topic>Biological research</topic><topic>Biomedical Research</topic><topic>British American Tobacco</topic><topic>CAC</topic><topic>Chairman’s Advisory Conference (BAT)</topic><topic>Communication</topic><topic>Consumer Product Safety</topic><topic>Cooperation Centre for Scientific Research Relative to Tobacco</topic><topic>CORESTA</topic><topic>Councils</topic><topic>Denial (Psychology)</topic><topic>Disease</topic><topic>Documents</topic><topic>Epidemiology</topic><topic>GR&DC</topic><topic>Group Research and Development Centre</topic><topic>Humans</topic><topic>Information management</topic><topic>Laboratories</topic><topic>Liability</topic><topic>Litigation</topic><topic>Philip Morris (Australia) Limited</topic><topic>Philip Morris International</topic><topic>PMI</topic><topic>PML</topic><topic>Product development</topic><topic>Propaganda</topic><topic>Public health</topic><topic>R&D</topic><topic>Research & development</topic><topic>Research Paper</topic><topic>scientific research group</topic><topic>Smoking</topic><topic>Smoking - adverse effects</topic><topic>Smoking - psychology</topic><topic>smoking related disease</topic><topic>SRG</topic><topic>TIA</topic><topic>Tobacco</topic><topic>Tobacco Industry</topic><topic>Tobacco Institute of Australia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carter, S M</creatorcontrib><creatorcontrib>Chapman, S</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ABI/INFORM Collection</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Trade & Industry (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>Natural Science Collection (ProQuest)</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ABI/INFORM Trade & Industry</collection><collection>Agricultural Science Database</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Tobacco control</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carter, S M</au><au>Chapman, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Smoking, disease, and obdurate denial: the Australian tobacco industry in the 1980s</atitle><jtitle>Tobacco control</jtitle><addtitle>Tob Control</addtitle><date>2003-12</date><risdate>2003</risdate><volume>12</volume><issue>suppl 3</issue><spage>iii23</spage><epage>iii30</epage><pages>iii23-iii30</pages><issn>0964-4563</issn><eissn>1468-3318</eissn><abstract>Objective: To contrast the Australian tobacco industry’s awareness of the diseases caused by smoking with their aggressive public denial on the relation between smoking and disease in the 1980s. Design: Analysis of 325 industry documents from the world wide web. Results: In the 1980s Australian cigarette manufacturers were informed constantly by the international industry of the medical consensus that smoking caused disease. In addition Philip Morris (Australia) Limited received reports of Philip Morris’ international biological research programme and visited its Richmond research facility; and WD&HO Wills part funded, co-managed, and contributed research to the British American Tobacco groups’ biological research programme. Despite this knowledge, the Australian manufacturers had a policy of arguing to their employees, decision makers, and the general public that questions of smoking and disease were unresolved. The industry catalogued the literature, developed arguments against the main claims made by health groups, and attacked public health advocates who made statements linking smoking to death and disease. Industry studies suggested that a 20–30% minority of the Australian public agreed with the industry on smoking and disease, diminishing across the decade. Conclusion: Australian manufacturers were clearly negligent in the 1980s, deliberately working to undermine Australians’ understandings of the diseases caused by smoking despite their own private knowledge. Continuing scepticism about smoking and disease, corresponding with the industry’s deceptions, exists in Australian smokers today, suggesting that their actions may have slowed the rate of decline in smoking prevalence. These revelations provide important evidence for Australian litigation and advocacy.</abstract><cop>England</cop><pub>BMJ Publishing Group Ltd</pub><pmid>14645945</pmid><doi>10.1136/tc.12.suppl_3.iii23</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0964-4563 |
ispartof | Tobacco control, 2003-12, Vol.12 (suppl 3), p.iii23-iii30 |
issn | 0964-4563 1468-3318 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1766119 |
source | Jstor Complete Legacy; MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
subjects | ACCI Advocacy Agreements Australia Australian Chamber of Commerce and Industry BAT Biological activity Biological research Biomedical Research British American Tobacco CAC Chairman’s Advisory Conference (BAT) Communication Consumer Product Safety Cooperation Centre for Scientific Research Relative to Tobacco CORESTA Councils Denial (Psychology) Disease Documents Epidemiology GR&DC Group Research and Development Centre Humans Information management Laboratories Liability Litigation Philip Morris (Australia) Limited Philip Morris International PMI PML Product development Propaganda Public health R&D Research & development Research Paper scientific research group Smoking Smoking - adverse effects Smoking - psychology smoking related disease SRG TIA Tobacco Tobacco Industry Tobacco Institute of Australia |
title | Smoking, disease, and obdurate denial: the Australian tobacco industry in the 1980s |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T18%3A20%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Smoking,%20disease,%20and%20obdurate%20denial:%20the%20Australian%20tobacco%20industry%20in%20the%201980s&rft.jtitle=Tobacco%20control&rft.au=Carter,%20S%20M&rft.date=2003-12&rft.volume=12&rft.issue=suppl%203&rft.spage=iii23&rft.epage=iii30&rft.pages=iii23-iii30&rft.issn=0964-4563&rft.eissn=1468-3318&rft_id=info:doi/10.1136/tc.12.suppl_3.iii23&rft_dat=%3Cproquest_pubme%3E4027267521%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1781842410&rft_id=info:pmid/14645945&rfr_iscdi=true |